Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:16 PM
Ignite Modification Date:
2025-12-24 @ 1:16 PM
NCT ID:
NCT04024995
Eligibility Criteria:
Inclusion Criteria:
* All patients with hematologic malignancies at any stage of the disease (acute myeloid leukemia, acute lymphoblastic leukemia, multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia, high and low grade non Hodgkin lymphoma, chronic myeloprolipherative disorders, Hodgkin lymphoma);
* Only inpatients will be eligible;
* Patient that start IV antifungal treatment (irrespective of previous prophylaxis);
* Informed consent signed.
Exclusion Criteria:
* Patients with previous or undergoing allogeneic or autologous transplant will be excluded from the study, due to different clinical profiles and risk factors;
* Patients treated, after prophylaxis with oral antifungals
* Patients treated in outpatient clinic or Day hospital
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04024995
Study Brief:
Protocol Section:
NCT04024995